The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Denosumab: A Review in Postmenopausal Osteoporosis
Abstract
Denosumab (Prolia ® ; Pralia ® ) is a human monoclonal antibody targeting the key bone resorption mediator RANKL. The drug is administered via subcutaneous injection once every 6 months and is approved for various indications, including the treatment of postmenopausal (PM) women with osteoporosis at increased/high risk of fracture or failure/intolerance of other osteoporosis therapies (indications featured in this review). Denosumab showed benefit in several phase 3 or 4 studies in PM women with osteoporosis or low bone mineral density (BMD), including the pivotal 3-year double-blind FREEDOM trial and its 7-year open-label extension. Denosumab reduced the risk of vertebral, nonvertebral and hip fractures and increased BMD across skeletal sites versus placebo in FREEDOM, with these benefits maintained over up to 10 years' therapy in the extension. The drug was also more effective in improving BMD than bisphosphonates, including in women switched from a bisphosphonate regimen, in 1-year trials; however, whether these differences translate into differences in anti-fracture efficacy is unclear. Denosumab was generally well tolerated over up to 10 years' treatment, although an increased risk of multiple vertebral fractures was observed after discontinuation of the drug. Thus, denosumab is a key treatment option for PM women with osteoporosis who have an increased/high risk of fracture or failure/intolerance of other osteoporosis therapies, although the potential for multiple verte…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“denosumab, has been shown to have undesirable side effects and, similar to biphosphonates, adversely affects osteoblastogenesis [71]”
From Osteoclasts and Microgravity (2020) · cites this paper as [71]
Citations
Cites
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Black, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,790
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996
Eastell, R., O’Neill, T. W., Hofbauer, L. C., Langdahl, B. L., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.69 · Cited by 877
Cummings, S. R., Ferrari, S., Eastell, R., Gilchrist, N. L., Jensen, J. B., McClung, M. R., Roux, C., Törring, O., Valter, I., Wang, A. T., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3337 · Cited by 753
Bone, H. G., Bolognese, M. A., Yuen, C. K., Kendler, D. L., Miller, P. D., Yang, Y., Grazette, L. P., Martín, J. S., & Gallagher, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1502 · Cited by 634
Brown, J. P., Prince, R. L., Deal, C. L., Recker, R. R., Kiel, D. P., de Gregorio, L. H., Hadji, P., Hofbauer, L. C., Álvaro‐Gracia, J. M., Wang, H., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0809010 · Cited by 616
Tsourdi, E. A., Langdahl, B. L., Cohen-Solal, M. E., Aubry‐Rozier, B., Eriksen, E. F., Guañabens, N., Obermayer-Pietsch, B. M., Ralston, S. H., Eastell, R., & Zillikens, M. C. (2017) · Bone · doi:10.1016/j.bone.2017.08.003 · Cited by 508
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 491
Research works printed but not linked: 2
- Zhang Y, Zhang L, Li S, et al. Effect of denosumab, a fully human monoclonal antibody to RANKL, on bone mineral density and fractures: a meta-analysis. Int J Clin Exp Med. 2017;10(4):5931–40.
- Insinga RP. Administration costs of denosumab and zoledronic acid for postmenopausal osteoporosis. Am J Pharm Benefits. 2016;8(3):e42–7.
Cited by
Sorted by citations
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Osteoporosis pathogenesis and treatment: existing and emerging avenues
Liang, B., Burley, G., Lin, S., & Shi, Y. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00371-3 · Cited by 250
The Human Gut Microbiota: A Key Mediator of Osteoporosis and Osteogenesis
Seely, K. D., Kotelko, C. A., Douglas, H. E., Bealer, B., & Brooks, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179452 · Cited by 209
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
Infante, M., Fabi, A., Cognetti, F., Gorini, S., Caprio, M., & Fabbri, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1001-2 · Cited by 180
Insights and implications of sexual dimorphism in osteoporosis
Zhang, Y., Xie, N., Sun, X., Nice, E. C., Liou, Y., Huang, C., Zhu, H., & Shen, Z. (2024) · Bone Research · doi:10.1038/s41413-023-00306-4 · Cited by 164
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion
Migliorini, F., Colarossi, G., Baroncini, A., Eschweiler, J., Tingart, M., & Maffulli, N. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1851192 · Cited by 149
Takegahara, N., Kim, H., & Choi, Y. (2022) · Bone · doi:10.1016/j.bone.2022.116353 · Cited by 136
Review and update on drugs related to the development of osteonecrosis of the jaw
Eguia, A., Bagán, L., & Cardona, F. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23191 · Cited by 117
The Development of Molecular Biology of Osteoporosis
Gao, Y., Patil, S., & Jia, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158182 · Cited by 116
Vascular calcification: Molecular mechanisms and therapeutic interventions
Pan, W. D., Jie, W., & Huang, H. (2023) · MedComm · doi:10.1002/mco2.200 · Cited by 121
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 129
Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism
Wu, Y., Yang, Y., Wang, L., Chen, Y., Han, X., Sun, L., Chen, H., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109296 · Cited by 85
Romosozumab in osteoporosis: yesterday, today and tomorrow
Wu, D., Li, L., Wen, Z., & Wang, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04563-z · Cited by 88
Genah, S., Monici, M., & Morbidelli, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094585 · Cited by 77
The osteoclast cytoskeleton – current understanding and therapeutic perspectives for osteoporosis
Blangy, A., Bompard, G., Guerit, D., Marie, P., Maurin, J., Morel, A., & Vives, V. (2020) · Journal of Cell Science · doi:10.1242/jcs.244798 · Cited by 76
Xue, Y., Hu, S., Chen, C., He, J., Sun, J., Jin, Y., Zhang, Y., Zhu, G., Shi, Q., & Rui, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63505 · Cited by 81
Mesenchymal stem cells and biologic factors leading to bone formation
Bartold, P. M., Gronthos, S., Haynes, D. A., & Ivanovski, S. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13053 · Cited by 67
The Mechanism of Bone Remodeling After Bone Aging
Fang, H., Deng, Z., Liu, J., Chen, S., Deng, Z., & Li, W. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s349604 · Cited by 71
A Review on the Role of Denosumab in Fracture Prevention
Pang, K.-L., Low, N. Y., & Chin, K. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s270829 · Cited by 67
Alessandro de, S. I. R. E., Invernizzi, M., Baricich, A., Lippi, L., Ammendolia, A., Grassi, F. A., & Leigheb, M. (2021) · World Journal of Orthopedics · doi:10.5312/wjo.v12.i7.456 · Cited by 61
Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments
Shapiro, C. L. (2020) · Cancers · doi:10.3390/cancers12113094 · Cited by 59
Smith, J. K. (2020) · Life · doi:10.3390/life10090207 · Cited by 52
Osteoporosis treatment in patients undergoing spinal fusion: a systematic review and meta-analysis
Govindarajan, V., Diaz, A., Perez-Roman, R. J., Burks, S. S., Wang, M. Y., & Levi, A. D. (2021) · Neurosurgical FOCUS · doi:10.3171/2021.3.focus2175 · Cited by 45
Greco, T., Mascio, A., Comisi, C., Polichetti, C., Caravelli, S., Mosca, M., Mondanelli, N., Troiano, E., Maccauro, G., & Perisano, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033014 · Cited by 49
Biomechanics of Implant Fixation in Osteoporotic Bone
Anderson, K. D., Ko, F. C., Virdi, A. S., Sumner, D. R., & Ross, R. D. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00614-2 · Cited by 44
Karimi, S. M., Bayat, M., & Rahimi, R. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.08.001 · Cited by 44
The Pathogenetic Role of RANK/RANKL/OPG Signaling in Osteoarthritis and Related Targeted Therapies
Cicco, G. D., Marzano, E., Mastrostefano, A., Pitocco, D., Castilho, R. S., Zambelli, R., Mascio, A., Greco, T., Cinelli, V., Comisi, C., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12102292 · Cited by 49
Skeletal dynamics of Down syndrome: A developing perspective
LaCombe, J., & Roper, R. J. (2019) · Bone · doi:10.1016/j.bone.2019.115215 · Cited by 43
Wang, X., Tian, Y. E., Liang, X., Yin, C., Huai, Y., Zhao, Y., Huang, Q., Chu, X., Wang, W., & Qian, A. (2022) · Food & Function · doi:10.1039/d1fo02755g · Cited by 41
Scimeca, M., Trivigno, D., Bonfiglio, R., Ciuffa, S., Urbano, N., Schillaci, O., & Bonanno, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.004 · Cited by 41
Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment
Zheng, Z., Yu, C., & Wei, H. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0168 · Cited by 39
Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis
Zhao, X., Patil, S., Xu, F., Lin, X., & Qian, A. (2021) · Biomolecules · doi:10.3390/biom11050747 · Cited by 38
Zheng, K., Bai, J., Li, N., Li, M., Sun, H., Zhang, W., Ge, G., Liang, X., Tao, H., Xue, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.039 · Cited by 36
Osteoporosis: molecular pathogenesis and therapeutic interventions
Zhang, X., Liang, Y., Zhang, F., & Liu, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00349-5 · Cited by 37
Mechanisms of Ferroptosis in bone disease: A new target for osteoporosis treatment
Wang, D., Shen, J., Wang, Y., Cui, H., Li, Y., Zhou, L., Li, G., Wang, Q., Feng, X., Qin, M., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111598 · Cited by 32
Roumpou, A., Palermo, A., Tournis, S., Hasenmajer, V., Pasieka, J. L., Kaltsas, G., Isidori, A. M., & Kassi, E. N. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf010 · Cited by 35
Denosumab in the treatment of glucocorticoid-induced osteoporosis
Benlidayı, İ. C. (2018) · Rheumatology International · doi:10.1007/s00296-018-4106-1 · Cited by 27
Polarization Profiles of T Lymphocytes and Macrophages Responses in Periodontitis
Cavalla, F., & Hernández, M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-96881-6_10 · Cited by 27
A Scoping Review of the Skeletal Effects of Naringenin
Muhamad, M. L. N., Ekeuku, S. O., Wong, S. K., & Chin, K. (2022) · Nutrients · doi:10.3390/nu14224851 · Cited by 27
Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease
Musio, A., Perazza, F., Leoni, L., Stefanini, B., Dajti, E., Menozzi, R., Petroni, M. L., Colecchia, A., & Ravaioli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087517 · Cited by 26
Pal, S., Sayeed, M., Kumar, A., Verma, D. P., Harioudh, M. K., Verma, N. K., Porwal, K., Sharma, S., Kulkarni, C., Bandyopadhyay, A., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01513 · Cited by 26
Kalinkovich, A., & Livshits, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105794 · Cited by 24
Bone-fracture-targeted dasatinib-oligoaspartic acid conjugate potently accelerates fracture repair
Wang, M., Park, S., Nam, Y., Nielsen, J., Low, S. A., Srinivasarao, M., & Low, P. S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00660 · Cited by 24
Bone-modifying Agents (BMAs) in Breast Cancer
Shapiro, C. L. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.04.009 · Cited by 26
Functional Validation of Osteoporosis Genetic Findings Using Small Fish Models
Kague, É., & Karasik, D. (2022) · Genes · doi:10.3390/genes13020279 · Cited by 26
Ahmad, S. S., Ahmed, F., Ali, R., Ghoneim, M. M., Alshehri, S., Najmi, A. K., Ahmad, S., Ahmad, M. Z., Ahmad, J., & Khan, M. A. (2022) · Immunotherapy · doi:10.2217/imt-2021-0282 · Cited by 25
Tan, X., Wen, F., Yang, W., Xie, J.-Y., Ding, L., & Mo, Y. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001321 · Cited by 24
Rauner, M., Foessl, I., Formosa, M. M., Kague, É., Prijatelj, V., Alonso, N., Banerjee, B., Bergen, D. J. M., Busse, B., Calado, Â., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731217 · Cited by 23
Rhee, Y., Chang, D., Ha, J., Kim, S., Lee, Y., Jo, E., & Koh, J. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1427 · Cited by 23
Ho, W.-C., Chang, C.-C., Wu, W., Lee, R., Yao, T.-K., Peng, C.-H., & Yeh, K. (2024) · Current Rheumatology Reports · doi:10.1007/s11926-024-01139-8 · Cited by 30
Passive Monoclonal and Polyclonal Antibody Therapies
Pelletier, J. P. R., & Mukhtar, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-67509-3.00016-0 · Cited by 23
Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis
Mueller, A., Brockmueller, A., Kunnumakkara, A. B., & Shakibaei, M. (2022) · Nutrients · doi:10.3390/nu14102030 · Cited by 25
Zhang, J., Fujita, Y., Chang, L., Pu, Y., Qu, Y., Wang, S., & Hashimoto, K. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112397 · Cited by 22
Wang, J., Tang, Y., Lv, X., Zhang, J., Ma, B., Wen, X., Bao, Y., & Wang, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111057 · Cited by 22
Uddin, J., Economidou, S. N., Guiraud, L., Kazi, M., Alanazi, F. K., & Douroumis, D. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00379 · Cited by 21
Smart biomaterials for skeletal aging repair and regeneration
Liang, D., Wang, H., Jiang, Y., Zhang, Z., Zhou, T., Ge, S., Tan, S., Qin, K., Wang, Y., Lin, X., et al. (2026) · Bone Research · doi:10.1038/s41413-026-00505-9 · Cited by 25
Etani, Y., Ebina, K., Hirao, M., Kitaguchi, K., Kashii, M., Ishimoto, T., Nakano, T., Okamura, G., Miyama, A., Takami, K., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115525 · Cited by 21
Study on synergistic effects of carboxymethyl cellulose and LIPUS for bone tissue engineering
Tang, L., Wu, T., Zhou, Y., Zhong, Y., Sun, L., Guo, J., Fan, X., & Ta, D. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119278 · Cited by 20
New Function of Cholesterol Oxidation Products Involved in Osteoporosis Pathogenesis
Che, Y., Yang, J., Tang, F., Wei, Z., Chao, Y., Li, N., Li, H., Wu, S., & Dong, X. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042020 · Cited by 20
Reginster, J., Czerwinski, E. J., Wilk, K., Borowy, P., Strzelecka, A., Budlewski, T., Janowska-Maus, M., Szymanowski, K., Kwiatek, J., Postol, S., et al. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07161-x · Cited by 19
Ishii, T., Ruiz‐Torruella, M., Yamamoto, K., Yamaguchi, T., Heidari, A., Pierrelus, R., Leon, E., Shindo, S., Rawas-Qalaji, M., Pastore, M. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105630 · Cited by 18
Yamaguchi, Y., Morita, T., & Kumanogoh, A. (2020) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaa008 · Cited by 20
Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
Stumpf, U. C., Kraus, M., & Hadji, P. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06008-z · Cited by 18
Pacheco-Soto, B. T., Elguezabal-Rodelo, R. G., Porchia, L. M., Torres‐Rasgado, E., Pérez-Fuentes, R., & González-Mejía, M. E. (2021) · Journal of Drug Assessment · doi:10.1080/21556660.2021.1989194 · Cited by 18
Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
Majdoub, F., Ferjani, H. L., Nessib, D. B., Kaffel, D., Maatallah, K., & Hamdi, W. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346058.029 · Cited by 19
Beneficial effects of Cirsium japonicum var. maackii on menopausal symptoms in ovariectomized rats
Park, J. Y., Yun, H., Jo, J., Baek, J. Y., Lee, S. C., Choi, Y. J., Shim, J. S., Choi, H. J., Lee, S., & Kang, K. S. (2018) · Food & Function · doi:10.1039/c7fo01258f · Cited by 18
Liu, B., Gao, F., Xiu, X., Wu, T., Liu, Z., Zhang, B., Liu, S., & Han, Y. (2022) · Orthopaedic Surgery · doi:10.1111/os.13584 · Cited by 18
Role of ubiquitination in the occurrence and development of osteoporosis (Review)
Fan, X., Zhang, R., Xu, G., Fan, P., Luo, W., Cai, C., & Ge, R. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5392 · Cited by 17
Deng, W., Huang, Y., Li, H., Chen, C., Lin, Y., Wang, M., Huang, H., Liu, T., Qin, Q., Shao, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015693 · Cited by 17
Yang, J., Guo, X., Cui, Z., Guo, H., & Dong, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431676 · Cited by 17
Zheng, D., Cui, C., Shao, C., Wang, Y., Ye, C., & Lv, G. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22778 · Cited by 15
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer
Dhabhar, B. N. (2022) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s353332 · Cited by 15
Rahmani, D., Faal, B., Zali, H., Tackallou, S. H., & Niknam, Z. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04167-6 · Cited by 14
Mounier, L., Morel, A., Ferrandez, Y., Morko, J. P., Vääräniemi, J., Gilardone, M., Roche, D., Cherfils, J., & Blangy, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01201 · Cited by 15
Lien, C., Lu, C., Lin, Y., Wu, W.-J., Hsu, C.-H., Chuang, T.-Y., Lin, K., Chuang, W., Lee, M.-C., & Wu, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5548968 · Cited by 14
Boonyayothin, W., Sinnung, S., Shanmugaraj, B., Abe, Y., Strasser, R., Pavasant, P., & Phoolcharoen, W. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.683417 · Cited by 12
He, B., Kong, L., Yang, X., Zheng, H., Liu, Y., & Hao, D. (2019) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666190703143946 · Cited by 12
Preventing osteolytic lesions and osteomyelitis in multiple myeloma
Dao, A., McDonald, M. M., Savage, P. B., Little, D. G., & Schindeler, A. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100460 · Cited by 12
Denosumab-Induced Immune Hepatitis
Ostrovsky, V., Malnick, S. D. H., Ish-Shalom, S., Ziv‐Sokolovskaya, N., Yosepovich, A., & Neuman, M. G. (2021) · Biomedicines · doi:10.3390/biomedicines9010076 · Cited by 11
Huang, C., Shiao, M., & Mao, T. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s316144 · Cited by 11
Muñoz-García, J., Heymann, D., Giurgea, I., Legendre, M., Amselem, S., Castañeda, B., Lézot, F., & Vargas-Franco, J. W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115584 · Cited by 11
Periprosthetic osteolysis: Mechanisms and potential treatment strategies
Yao, F., Bao, Y., Meng, Q., Chen, Y., Zhao, L., Wang, P. Y., & Zhou, B. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111758 · Cited by 10
The Role of Ferroptosis in Osteoporosis and Advances in Chinese Herbal Interventions
Li, P., Xu, T., Yu, A.-X., Liang, J., Zhou, Y.-S., Sun, H., Dai, Y., Liu, J., & Yu, P. (2025) · Biology · doi:10.3390/biology14040367 · Cited by 10
Denosumab might prevent periprosthetic bone loss after total hip and knee arthroplasties: a review
Xu, J., Li, H., Qu, Y., Zheng, C. R., Wang, B., Shen, P., Xie, Z., Wei, K., Wang, Y., & Zhao, J. (2021) · Arthroplasty · doi:10.1186/s42836-021-00068-6 · Cited by 10
Li, X., Han, J., Shi, X., Bi, Z., & Liu, J. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01227-9 · Cited by 10
Noguchi, T., Sakamoto, A., Murotani, Y., Murata, K., Hirata, M., Yamada, Y., Toguchida, J., & Matsuda, S. (2023) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554231163638 · Cited by 10
van Rietbergen, B., Biver, E., Chevalley, T., Ito, K., Chapurlat, R. D., & Ferrari, S. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4285 · Cited by 10
Wang, S., Yuan, Y., Lin, Q., Zhou, H., Tang, B., Liu, Y., Huang, H., Liang, B., Mao, Y., Liu, K., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.937538 · Cited by 10
An Overview of Osteoporosis and Possible Treatment Approaches
Abo-Elenin, M. H. H., Kamel, R., Nofal, S., & Ahmed, A. A. E. (2024) · Clinical & Translational Metabolism · doi:10.1007/s12018-024-09291-6 · Cited by 9
Si, Y., Yao, Y., Ma, Y., Guo, Y., & Yin, H. (2020) · Medicine · doi:10.1097/md.0000000000020773 · Cited by 9
Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
Kratochvílová, A., Ramešová, A., Veselá, B., Švandová, E., Lesot, H., Gruber, R., & Matalová, E. (2021) · Biology · doi:10.3390/biology10080757 · Cited by 9
Piñera-Avellaneda, D., Buxadera‐Palomero, J., Ginebra, M., Rupérez, E., & Manero, J. M. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1303313 · Cited by 9
Current and emerging bone resorption inhibitors for the treatment of osteoporosis
Gogakos, A. I., & Anastasilakis, A. D. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2451741 · Cited by 9
Platelet factor 4 induces bone loss by inhibiting the integrin α5‐FAK‐ERK pathway
Li, W., Zhang, Q., Gu, R., Zeng, L., & Liu, H. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12342 · Cited by 8
Sheu, S., Hsu, Y.-K., Chuang, M., Chu, C., Lin, P., Liao, J.-H., Lin, S., & Kuo, T. (2020) · Cell Transplantation · doi:10.1177/0963689720927398 · Cited by 8
Mazza, O., Gluck, C., Menkes-Caspi, N., Bornstein, R. J., Amir, H., Bahar, M., & Haim, A. (2025) · Bone Reports · doi:10.1016/j.bonr.2025.101869 · Cited by 7
Aryana, I. G. P. S., Rini, S. S., & Setiati, S. (2023) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.22.0139 · Cited by 7
RetractedUsing sequential pharmacotherapy for the treatment of osteoporosis: an update of the literature
Mondo, I., Hannou, S., & D’Amelio, P. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2296543 · Cited by 8
DeNapoli, R. C., Buettmann, E. G., Friedman, M. A., Lichtman, A. H., & Donahue, H. J. (2022) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2022.111414 · Cited by 7
Role of biophysical stimulation in multimodal management of vertebral compression fractures
Martino, A. C. D., Villari, E., Poluzzi, R., Brunello, M., Rossomando, V., D’Agostino, C., Ruta, F., & Faldini, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.023 · Cited by 7
Metadata
- Authors
- Deeks, E. D.
- Affiliations
- Springer Nature (New Zealand) (NZ)
- Corresponding author
- Deeks, Emma D.
- Venue
- Drugs & Aging
- Published
- 2018-02
- Volume
- 35
- Issue
- 2
- Pages
- 163-173
- ISSN
- 1170-229X (ISSN-L)
- 1179-1969
- OpenAlex
- W2792392055
- Cited by
- 169
- References
- 55
- Citations by year
- 2026: 7 · 2025: 23 · 2024: 16 · 2023: 22 · 2022: 32 · 2021: 37 · 2020: 19 · 2019: 10 · 2018: 3
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-03-09)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- denosumab, postmenopausal osteoporosis, RANKL, monoclonal antibodies, fracture risk, vertebral fractures, hip fracture, osteopenia, FREEDOM trial, drug discontinuation, adverse events, long-term treatment
- MeSH terms
- Denosumab, Aged, Clinical Trials as Topic, Female, Humans, Bone Density, Osteoporosis, Postmenopausal, Treatment Outcome, Bone Density Conservation Agents, Fractures, Bone, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
